How long should a patient be off naltrexone (opioid receptor antagonist) before undergoing anesthesia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 17, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Duration to Hold Naltrexone Before Anesthesia

For oral naltrexone, discontinue 2-3 days before elective surgery if opioids will be needed perioperatively; for extended-release naltrexone (Vivitrol), discontinue 24-30 days after the last injection. 1

Oral Naltrexone Timing

  • Hold oral naltrexone for 2-3 days prior to elective surgical procedures when perioperative opioid use is anticipated. 1
  • The plasma half-life of naltrexone is 4 hours, but its active metabolite (6-β-naltrexol) has a 13-hour half-life that accumulates during long-term therapy, causing antagonist effects to persist for 2-3 days after stopping. 1, 2
  • This 2-3 day washout period allows sufficient clearance of both naltrexone and its active metabolite to restore opioid receptor responsiveness for adequate perioperative analgesia. 1

Extended-Release Naltrexone (Vivitrol) Timing

  • Extended-release naltrexone must be held for 24-30 days after the last injection before elective surgical procedures if opioids are expected to be used perioperatively. 1
  • The prolonged duration of action from the depot formulation requires this extended washout period to ensure opioid analgesics will be effective. 1
  • Patients on extended-release naltrexone who require urgent surgery may experience inadequate pain control from opioids and need alternative analgesic strategies including regional anesthesia, non-opioid systemic agents, or general anesthesia techniques that minimize opioid requirements. 3

Critical Clinical Pitfalls

  • Patients who have not been off naltrexone for adequate duration may be completely refractory to opioid analgesia, requiring significantly higher opioid doses that can lead to serious complications including respiratory depression once the naltrexone blockade wears off. 4
  • Some patients on long-term extended-release naltrexone may develop opioid receptor upregulation, paradoxically making them more sensitive to dangerous opioid side effects (particularly respiratory depression) when the blockade is overcome. 1, 4
  • Patients discontinuing naltrexone are at markedly increased risk of opioid overdose and death due to loss of opioid tolerance during treatment, requiring careful counseling about this risk. 3, 5
  • If naltrexone cannot be discontinued for the recommended duration before urgent/emergent surgery, inform the anesthesiologist immediately so alternative pain management strategies can be implemented. 1

Verification Before Surgery

  • Confirm the patient has been completely opioid-free (including tramadol) for a minimum of 7-10 days before starting naltrexone to avoid precipitated withdrawal when restarting postoperatively. 5
  • Document the exact date of the last naltrexone dose (oral) or injection (extended-release) to calculate appropriate washout time. 1
  • Consider a naloxone challenge test if there is uncertainty about adequate opioid-free period, though this should not be performed in patients showing clinical signs of withdrawal or with opioids detected in urine. 5

Alternative Analgesic Strategies When Inadequate Washout Time

  • Employ multimodal analgesia with non-opioid agents including acetaminophen, NSAIDs, gabapentinoids, ketamine, and regional anesthesia techniques. 3, 6
  • General anesthesia alone (without reliance on opioid analgesia) may be necessary for surgical procedures. 3
  • Be prepared that even with these strategies, pain control may be inadequate if naltrexone blockade persists. 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid Antagonist Pharmacology and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Naltrexone Contraindications and Alternatives for Pain Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the guidelines for discontinuing naltrexone (opioid receptor antagonist) prior to anesthesia in a patient with a history of opioid dependence or addiction?
Would administration of low-dose oral hydromorphone, as needed (prn), to a patient on naltrexone (Naltrexone) cause adverse effects for severe knee pain management?
How many days does it take for low-dose naltrexone (0.25 mg) to reach peak effects when used to assist in an opioid (opiate) taper?
Is naltrexone (opioid receptor antagonist) suitable for a 15-year-old?
Can a patient who has been abstinent from alcohol for 6 days start taking naltrexone (opioid receptor antagonist)?
What are the necessary precautions and monitoring requirements for a patient 1-2 weeks after thyroidectomy?
Can a 62-year-old diabetic patient with hyperglycemia (elevated blood sugar), stable vitals, and symptoms of cough and breathing difficulty suddenly go into cardiac arrest?
Is it appropriate to treat pneumonia (pna) with doxycycline (doxy) and piperacillin-tazobactam (zosyn) for a patient with possible hospital-acquired pneumonia (HAP) and aspiration pneumonia?
What are the guidelines for discontinuing naltrexone (opioid receptor antagonist) prior to anesthesia in a patient with a history of opioid dependence or addiction?
What is the initial management for a patient presenting with acute dyspnea?
What is the appropriate initial evaluation and management for an 11-year-old patient presenting with transient numbness of the lip, tongue, and left hand that resolved spontaneously after 30 minutes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.